Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOCAL trial of intra-arterial tenecteplase after successful thrombectomy for anterior circulation ischemic stroke
2024-516544-26-00Phase 2Authorised
- Sponsor
- Heidelberg University Hospital
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Intra-arterial tenecteplase after successful recanalization with Placebo after successful recanalization (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Mar 2026; status: authorised.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2024-516544-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516544-26-00.